BRPI0924078A2 - n-glicanos contendo galactose-alfa-1,3-galactose em produtos de glicoproteína derivados de células de cho. - Google Patents
n-glicanos contendo galactose-alfa-1,3-galactose em produtos de glicoproteína derivados de células de cho.Info
- Publication number
- BRPI0924078A2 BRPI0924078A2 BRPI0924078A BRPI0924078A BRPI0924078A2 BR PI0924078 A2 BRPI0924078 A2 BR PI0924078A2 BR PI0924078 A BRPI0924078 A BR PI0924078A BR PI0924078 A BRPI0924078 A BR PI0924078A BR PI0924078 A2 BRPI0924078 A2 BR PI0924078A2
- Authority
- BR
- Brazil
- Prior art keywords
- galactose
- alpha
- cho cell
- cell derived
- glycans containing
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- QIGJYVCQYDKYDW-SDOYDPJRSA-N alpha-D-galactosyl-(1->3)-D-galactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-SDOYDPJRSA-N 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Developmental Biology & Embryology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2009/031678 WO2010085251A1 (en) | 2009-01-22 | 2009-01-22 | Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from cho cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0924078A2 true BRPI0924078A2 (pt) | 2018-10-16 |
Family
ID=40524730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0924078A BRPI0924078A2 (pt) | 2009-01-22 | 2009-01-22 | n-glicanos contendo galactose-alfa-1,3-galactose em produtos de glicoproteína derivados de células de cho. |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8586356B2 (pt) |
| EP (1) | EP2389586B2 (pt) |
| JP (1) | JP2012515922A (pt) |
| KR (1) | KR20110119702A (pt) |
| CN (1) | CN102292640B (pt) |
| AU (1) | AU2009338190C1 (pt) |
| BR (1) | BRPI0924078A2 (pt) |
| CA (1) | CA2749281C (pt) |
| IL (1) | IL213715A (pt) |
| MX (1) | MX2011007545A (pt) |
| NZ (1) | NZ593816A (pt) |
| RU (1) | RU2484142C2 (pt) |
| SG (1) | SG173078A1 (pt) |
| WO (1) | WO2010085251A1 (pt) |
| ZA (1) | ZA201104753B (pt) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110119702A (ko) | 2009-01-22 | 2011-11-02 | 모멘타 파머슈티컬스 인코포레이티드 | Cho 세포에서 유도된 글리코단백질 생성물에서의 갈락토오스-알파-1,3-갈락토오스-함유 n-글리칸 |
| ES2605677T3 (es) | 2009-11-11 | 2017-03-15 | Momenta Pharmaceuticals, Inc. | Glucosiltransferasa de hámster chino y métodos relacionados |
| US20130243744A1 (en) * | 2011-01-06 | 2013-09-19 | Michael J. Betenbaugh | Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells |
| JP2012189439A (ja) * | 2011-03-10 | 2012-10-04 | Sumitomo Bakelite Co Ltd | 糖鎖試料の製造方法 |
| US9062106B2 (en) | 2011-04-27 | 2015-06-23 | Abbvie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| WO2012158932A2 (en) * | 2011-05-18 | 2012-11-22 | University Of Massachusetts | REMOVAL OF α-GAL EPITOPES FROM THERAPEUTIC GLYCOPROTEINS FOR AVOIDING INTERACTION WITH THE ANTI-GAL ANTIBODY |
| US8980583B2 (en) | 2011-06-30 | 2015-03-17 | Sigma-Aldrich Co. Llc | Cells deficient in CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| WO2013181575A2 (en) | 2012-06-01 | 2013-12-05 | Momenta Pharmaceuticals, Inc. | Methods related to denosumab |
| EP2877589B1 (en) | 2012-07-26 | 2024-03-06 | Momenta Pharmaceuticals, Inc. | Glycoproteins with anti-inflammatory properties |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| EP2722673B1 (en) | 2012-10-17 | 2017-07-12 | Hexal AG | Improved method of mapping glycans of glycoproteins |
| CN105358577A (zh) * | 2013-02-13 | 2016-02-24 | 法国化学与生物科技实验室 | 具有经修饰的糖基化的西妥昔单抗及其用途 |
| HK1207960A1 (en) | 2013-03-12 | 2016-02-19 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| US9499614B2 (en) | 2013-03-14 | 2016-11-22 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides |
| US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| ES2802274T3 (es) | 2013-05-02 | 2021-01-18 | Momenta Pharmaceuticals Inc | Glicoproteínas sialiladas |
| WO2014186310A1 (en) | 2013-05-13 | 2014-11-20 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| WO2015057622A1 (en) | 2013-10-16 | 2015-04-23 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| US11275090B2 (en) | 2014-11-19 | 2022-03-15 | Amgen Inc. | Quantitation of glycan moiety in recombinant glycoproteins |
| CN105820248A (zh) * | 2015-01-07 | 2016-08-03 | 上海张江生物技术有限公司 | 一种新型抗egfr单克隆抗体的制备方法及应用 |
| FR3038517B1 (fr) | 2015-07-06 | 2020-02-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Utilisation de fragments fc modifies en immunotherapie |
| EP3397282A4 (en) | 2015-12-30 | 2019-08-07 | Momenta Pharmaceuticals, Inc. | METHODS RELATING TO BIOLOGICA |
| US12595454B2 (en) | 2018-09-06 | 2026-04-07 | Momenta Pharmaceuticals, Inc. | Methods of continuous cell culture |
| US20210353752A1 (en) | 2018-10-11 | 2021-11-18 | Momenta Pharmaceuticals, Inc. | Treatment with highly silylated igg compositions |
| EA202191253A1 (ru) * | 2018-11-08 | 2021-12-07 | МИДОРИ ЮЭсЭй, ИНК. | Способы количественного определения олигосахаридных препаратов |
| IL284374B2 (en) * | 2018-12-31 | 2025-10-01 | Momenta Pharmaceuticals Inc | Methods for producing ozatekinumab |
| US11267853B2 (en) * | 2019-01-28 | 2022-03-08 | University Of Rhode Island Board Of Trustees | Carbohydrate tethering at cell surfaces to induce immune response |
| CN109932445A (zh) * | 2019-03-19 | 2019-06-25 | 北京泰德制药股份有限公司 | 一种糖蛋白多种电荷异构体n糖链结构的评价方法 |
| CA3174533A1 (en) * | 2020-03-05 | 2021-09-10 | Momenta Pharmaceuticals, Inc. | Methods of making hyper-sialylated immunoglobulin |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527681A (en) * | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
| US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| AU8007791A (en) | 1990-06-15 | 1992-01-07 | Cytel Corporation | Intercellular adhesion mediators |
| RU2123338C1 (ru) * | 1990-06-15 | 1998-12-20 | Сайтел Корпорейшн | Фармацевтическая композиция на основе медиатора межклеточной адгезии (варианты), способ ингибирования межклеточной адгезии, способ лечения воспалительного заболевания, способ анализа тестируемого соединения на способность ингибировать клеточную адгезию, способ получения соединения |
| US5384261A (en) * | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
| US5288514A (en) * | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
| US5871997A (en) † | 1994-07-21 | 1999-02-16 | Alexion Pharmaceuticals, Inc. | Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes |
| US5695937A (en) * | 1995-09-12 | 1997-12-09 | The Johns Hopkins University School Of Medicine | Method for serial analysis of gene expression |
| KR20040032105A (ko) | 2001-06-04 | 2004-04-14 | 엠엘 래보러토리즈 피엘씨 | 재조합 단백질의 조성물 및 재조합 단백질의 고수준대규모 생산방법 |
| US7651847B2 (en) * | 2004-06-22 | 2010-01-26 | The Regents Of The University Of California | Methods of oligosaccharide profiling for the detection of cancer |
| US7846724B2 (en) * | 2006-04-11 | 2010-12-07 | Hoffmann-La Roche Inc. | Method for selecting CHO cell for production of glycosylated antibodies |
| JP4808542B2 (ja) * | 2006-04-27 | 2011-11-02 | 公益財団法人野口研究所 | 糖鎖異性体を分離同定する質量分析法 |
| EP3539981A1 (en) † | 2006-09-10 | 2019-09-18 | Glycotope GmbH | Use of human cells of myeloid leukaemia origin for expression of antibodies |
| ES2626080T3 (es) | 2007-04-16 | 2017-07-21 | Momenta Pharmaceuticals, Inc. | Caracterización de N-glicanos utilizando exoglicosidasas |
| KR20110119702A (ko) | 2009-01-22 | 2011-11-02 | 모멘타 파머슈티컬스 인코포레이티드 | Cho 세포에서 유도된 글리코단백질 생성물에서의 갈락토오스-알파-1,3-갈락토오스-함유 n-글리칸 |
-
2009
- 2009-01-22 KR KR1020117018800A patent/KR20110119702A/ko not_active Ceased
- 2009-01-22 WO PCT/US2009/031678 patent/WO2010085251A1/en not_active Ceased
- 2009-01-22 AU AU2009338190A patent/AU2009338190C1/en not_active Ceased
- 2009-01-22 NZ NZ593816A patent/NZ593816A/xx not_active IP Right Cessation
- 2009-01-22 JP JP2011547891A patent/JP2012515922A/ja active Pending
- 2009-01-22 RU RU2011134491/10A patent/RU2484142C2/ru active
- 2009-01-22 CN CN200980155081.XA patent/CN102292640B/zh active Active
- 2009-01-22 EP EP09789435.6A patent/EP2389586B2/en active Active
- 2009-01-22 US US12/529,109 patent/US8586356B2/en active Active
- 2009-01-22 CA CA2749281A patent/CA2749281C/en active Active
- 2009-01-22 SG SG2011052610A patent/SG173078A1/en unknown
- 2009-01-22 MX MX2011007545A patent/MX2011007545A/es active IP Right Grant
- 2009-01-22 BR BRPI0924078A patent/BRPI0924078A2/pt not_active Application Discontinuation
-
2011
- 2011-06-22 IL IL213715A patent/IL213715A/en active IP Right Grant
- 2011-06-27 ZA ZA2011/04753A patent/ZA201104753B/en unknown
-
2013
- 2013-10-17 US US14/056,674 patent/US20140045212A1/en not_active Abandoned
-
2015
- 2015-08-21 US US14/832,784 patent/US10023894B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009338190A1 (en) | 2011-07-14 |
| US20160053292A1 (en) | 2016-02-25 |
| EP2389586A1 (en) | 2011-11-30 |
| IL213715A (en) | 2016-02-29 |
| JP2012515922A (ja) | 2012-07-12 |
| CN102292640A (zh) | 2011-12-21 |
| MX2011007545A (es) | 2011-10-28 |
| WO2010085251A1 (en) | 2010-07-29 |
| SG173078A1 (en) | 2011-08-29 |
| KR20110119702A (ko) | 2011-11-02 |
| EP2389586B2 (en) | 2018-01-24 |
| RU2011134491A (ru) | 2013-02-27 |
| US20110045496A1 (en) | 2011-02-24 |
| US8586356B2 (en) | 2013-11-19 |
| NZ593816A (en) | 2012-11-30 |
| ZA201104753B (en) | 2012-12-27 |
| US10023894B2 (en) | 2018-07-17 |
| EP2389586B1 (en) | 2014-06-25 |
| IL213715A0 (en) | 2011-07-31 |
| CA2749281A1 (en) | 2010-07-29 |
| CN102292640B (zh) | 2014-07-02 |
| AU2009338190B2 (en) | 2014-04-10 |
| US20140045212A1 (en) | 2014-02-13 |
| RU2484142C2 (ru) | 2013-06-10 |
| AU2009338190C1 (en) | 2014-07-17 |
| CA2749281C (en) | 2016-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0924078A2 (pt) | n-glicanos contendo galactose-alfa-1,3-galactose em produtos de glicoproteína derivados de células de cho. | |
| BRPI1009416A2 (pt) | célula solar. | |
| BR112012000107A2 (pt) | receptores de células t. | |
| HRP20150107T1 (xx) | Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola | |
| BRPI1007047A2 (pt) | Biorrefino irganosolv de cana-de-açúcar inteira. | |
| AP2011005548A0 (en) | Heterogeneous hydrogen-catalyst reactor. | |
| BRPI0911695A2 (pt) | conjunto de barbear | |
| EP2262624A4 (en) | shaving | |
| BRPI1011965A2 (pt) | estrutura de entressola. | |
| BRPI0914208A2 (pt) | célula de eletrólise, e, método | |
| BRPI1007507A2 (pt) | recipiente de dispensação, e, acessório fixado a um recipiente de dispensação. | |
| AP2010005473A0 (en) | Solar stills. | |
| BRPI1007811A2 (pt) | nacela de turborreator, e, turborreator | |
| FR2937889B1 (fr) | Installation de nettoyage de recipients. | |
| IT1393382B1 (it) | Tappo per serbatoi, in particolare per motocicli. | |
| BRPI1013157A2 (pt) | meio de fixação. | |
| BR112012001062A2 (pt) | laminados com microtextura. | |
| FR2941674B1 (fr) | Nacelle de turboreacteur. | |
| IT1392509B1 (it) | Dispositivo di protezione, con effetto aerodinamico, per motoveicolo. | |
| CL2008001260S1 (es) | Botella. | |
| BR112012002307A2 (pt) | mecanismo de came. | |
| IT1394641B1 (it) | Struttura di rasoio perfezionato. | |
| FI20096171L (fi) | Menetelmä hissijärjestelmän yhteydessä, sekä hissijärjestelmä | |
| BR112012001500A2 (pt) | produto moldado por painés automotivos. | |
| IT1396618B1 (it) | Contenitore per bombola. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |